𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Detectable BRAF mutation in serum DNA samples from patients with papillary thyroid carcinomas

✍ Scribed by Tony C. Y. Chuang; Alice Y. C. Chuang; Luana Poeta; Wayne M. Koch; Joseph A. Califano; Ralph P. Tufano

Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
123 KB
Volume
32
Category
Article
ISSN
1043-3074

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Background.

An activating point mutation of the BRAF oncogene results in a V600E amino acid missense mutation found in a majority of papillary thyroid carcinomas (PTC).

Methods.

In this study, 28 matched tumor and serum samples obtained from patients with both benign and malignant thyroid disorders were analyzed for BRAF mutation using a gap‐ligase chain reaction technique.

Results.

The BRAF mutation was absent in tumor DNA samples obtained from patients with benign adenomas, follicular neoplasms or carcinoma, and thyroid lymphoma. In contrast, 5 of 14 PTC tumors were positive for the BRAF mutation. Moreover, 3 of 14 patients with PTC were positive for BRAF mutation in serum and tumor. Of these 3 patients, 2 had lymph node metastasis and 2 had PTC in background of the Hashimoto's thyroiditis.

Conclusions.

The detection of free circulating mutant BRAF in patients with PTC is possible and future studies are warranted to determine its clinical significance. Β© 2009 Wiley Periodicals, Inc. Head Neck, 2010

πŸ“œ SIMILAR VOLUMES

The presence of BRAF point mutation in a
The presence of BRAF point mutation in adult papillary thyroid carcinomas from atomic bomb survivors correlates with radiation dose
✍ Keiko Takahashi; Hidetaka Eguchi; Koji Arihiro; Reiko Ito; Kojiro Koyama; Midori πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 138 KB

## Abstract In papillary thyroid carcinogenesis, the constitutively activated mitogen‐activated protein (MAP) kinase signaling pathway caused by a genetic alteration such as __RET__/__PTC__ rearrangement or mutation of __RAS__ and __BRAF__ genes, is thought to be a major early event. Among these, t

High prevalence of BRAF mutation in a Br
High prevalence of BRAF mutation in a Brazilian cohort of patients with sporadic papillary thyroid carcinomas : Correlation with more aggressive phenotype and decreased expression of iodide-metabolizing genes
✍ Gisele Oler; Janete M. Cerutti πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 166 KB

## Abstract ## BACKGROUND: Although several studies undoubtedly demonstrated that __BRAF__ mutation is an important genetic event in the pathogenesis of papillary thyroid carcinoma (PTC), its prognostic significance and correlation with less differentiated states remains unclear. It has been sugge